KLF15 is a protective regulatory factor of heart failure induced by pressure overload

Zou,Shu‑Fan; Yu,Yang; Peng,Yan; Xiao,Ying‑Bin; Jian,Zhao; Jiang,Yun‑Han; Chen,Sai; Tang,Fu‑Qin; Chen,Lin

doi:10.3892/mmr.2020.10913

KLF15 is a protective regulatory factor of heart failure induced by pressure overload

Authors:
- Shu‑Fan Zou
- Yang Yu
- Yan Peng
- Ying‑Bin Xiao
- Zhao Jian
- Yun‑Han Jiang
- Sai Chen
- Fu‑Qin Tang
- Lin Chen
View Affiliations

Affiliations: Department of Cardiovascular Surgery, Xinqiao Hospital Affiliated to Army Medical University, Chongqing 400030, P.R. China, Department of Cardiology, Daping Hospital Affiliated to Army Medical University, Chongqing 400042, P.R. China
Published online on: January 8, 2020 https://doi.org/10.3892/mmr.2020.10913
Pages: 1336-1345

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the protective effect of Kruppel‑like factor 15 (KLF15) overexpression on heart failure (HF) induced by left ventricular (LV) pressure overload in mice. Wild‑type (WT) mice and cardiac‑specific KLF15‑overexpressed transgenic (TG) mice were selected as research subjects, and an LV pressure overload model was constructed by ascending aortic constriction surgery. Changes in cardiac morphology and function, and ultrastructure and molecular expression were observed via M‑mode echocardiography, histological and immunohistochemical staining, ELISA and western blotting at 2 and 6 weeks of LV overload. WT and TG mice subjected to 2 weeks of overload displayed adaptive LV hypertrophy characterized by ventricular thickness, cardiomyocyte size, ejection fraction and fractional shortening of heart‑lung weight ratio and KLF15, and increases in vascular endothelial growth factor (VEGF) expression without other pathological changes. WT mice subjected to 6 weeks of overload displayed enlargement of the LV chamber, severe interstitial remodeling, and HW/LW, cardiac capillary and heart function decline, accompanied by downregulated expression of KLF15 and VEGF, and upregulated expression of connective tissue growth factor, phosphorylated p38 (p‑p38) and phosphorylated Smad3 (p‑Smad3). In contrast, TG mice exhibited improved resistance to 6 weeks of overload and a slighter molecular expression response compared with WT mice. KLF15 was revealed to be a critical factor regulating the expression of CTGF, VEGF, p‑p38 and p‑Smad3, and could alleviate the progression from adaptive LV hypertrophy to decompensatory cardiac insufficiency.

View Figures

View References

1	Akinkuolie AO, Aleardi M, Ashaye AO, Gaziano JM and Djousse L: Height and risk of heart failure in the Physicians' Health Study. Am J Cardiol. 109:994–997. 2012. View Article : Google Scholar : PubMed/NCBI
2	Xu R, Lin F, Zhang S, Chen X, Hu S and Zheng Z: Signal pathways involved in reverse remodeling of the hypertrophic rat heart after pressure unloading. Int J Cardiol. 143:414–423. 2010. View Article : Google Scholar : PubMed/NCBI
3	Christia P, Bujak M, Gonzalez-Quesada C, Chen W, Dobaczewski M, Reddy A and Frangogiannis NG: Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction. J Histochem Cytochem. 61:555–570. 2013. View Article : Google Scholar : PubMed/NCBI
4	Ruwhof C and van der Laarse A: Mechanical stress-induced cardiac hypertrophy: Mechanisms and signal transduction pathways. Cardiovasc Res. 47:23–37. 2000. View Article : Google Scholar : PubMed/NCBI
5	Bernardo BC, Weeks KL, Pretorius L and McMullen JR: Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies. Pharmacol Ther. 128:191–227. 2010. View Article : Google Scholar : PubMed/NCBI
6	Berk BC, Fujiwara K and Lehoux S: ECM remodeling in hypertensive heart disease. J Clin Invest. 117:568–575. 2007. View Article : Google Scholar : PubMed/NCBI
7	Baudino TA, Carver W, Giles W and Borg TK: Cardiac fibroblasts: Friend or foe? Am J Physiol Heart Circ Physiol. 291:H1015–H1026. 2006. View Article : Google Scholar : PubMed/NCBI
8	Leenders JJ, Wijnen WJ, van der Made I, Hiller M, Swinnen M, Vandendriessche T, Chuah M, Pinto YM and Creemers EE: Repression of cardiac hypertrophy by KLF15: Underlying mechanisms and therapeutic implications. PLoS One. 7:e367542012. View Article : Google Scholar : PubMed/NCBI
9	Yu Y, Ma J, Xiao Y, Yang Q, Kang H, Zhen J, Yu L and Chen L: KLF15 is an essential negative regulatory factor for the cardiac remodeling response to pressure overload. Cardiology. 130:143–152. 2015. View Article : Google Scholar : PubMed/NCBI
10	Oka T, Akazawa H, Naito AT and Komuro I: Angiogenesis and cardiac hypertrophy: Maintenance of cardiac function and causative roles in heart failure. Circ Res. 114:565–571. 2014. View Article : Google Scholar : PubMed/NCBI
11	Fisch S, Gray S, Heymans S, Haldar SM, Wang B, Pfister O, Cui L, Kumar A, Lin Z, Sen-Banerjee S, et al: Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc Natl Acad Sci USA. 104:7074–7079. 2007. View Article : Google Scholar : PubMed/NCBI
12	Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, Miyamoto S, Kawai-Kowase K, Moriyama N, Imai Y, Kawakami H, et al: Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med. 8:856–863. 2002. View Article : Google Scholar : PubMed/NCBI
13	Chin MT: KLF15 and cardiac fibrosis: The heart thickens. J Mol Cell Cardiol. 45:165–167. 2008. View Article : Google Scholar : PubMed/NCBI
14	Haldar SM, Lu Y, Jeyaraj D, Kawanami D, Cui Y, Eapen SJ, Hao C, Li Y, Doughman YQ, Watanabe M, et al: Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation. Sci Transl Med. 2:26ra262010. View Article : Google Scholar : PubMed/NCBI
15	Yu Y, Zou S, Yang Q, Xiao Y, Yan Y, Chen H, Wu H, Luo Y, Yu P and Chen L: KLF15 is a positive regulatory factor in the process of myocardial remodeling and angiogenesis induced by pressure overload. Int J Clin Exp Med. 9:13394–13406. 2016.
16	Simoes PA, Zamarioli A, Bloes P, Mazzocato FC, Pereira LH, Volpon JB and Shimano AC: Effect of treadmill exercise on lumbar vertebrae in ovariectomized rats: Anthropometrical and mechanical analyses. Acta Bioeng Biomech. 10:39–41. 2008.PubMed/NCBI
17	Karamanolis G, Delladetsima I, Kouloulias V, Papaxoinis K, Panayiotides I, Haldeopoulos D, Triantafyllou K, Kelekis N and Ladas SD: Increased expression of VEGF and CD31 in postradiation rectal tissue: Implications for radiation proctitis. Mediators Inflamm. 2013:5150482013. View Article : Google Scholar : PubMed/NCBI
18	Yan L, Wei X, Tang QZ, Feng J, Zhang Y, Liu C, Bian ZY, Zhang LF, Chen M, Bai X, et al: Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling. Cardiovasc Res. 92:85–94. 2011. View Article : Google Scholar : PubMed/NCBI
19	Wynn TA and Ramalingam TR: Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nat Med. 18:1028–1040. 2012. View Article : Google Scholar : PubMed/NCBI
20	Koitabashi N, Danner T, Zaiman AL, Pinto YM, Rowell J, Mankowski J, Zhang D, Nakamura T, Takimoto E and Kass DA: Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload. J Clin Invest. 121:2301–2312. 2011. View Article : Google Scholar : PubMed/NCBI
21	Teekakirikul P, Eminaga S, Toka O, Alcalai R, Wang L, Wakimoto H, Nayor M, Konno T, Gorham JM, Wolf CM, et al: Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. J Clin Invest. 120:3520–3529. 2010. View Article : Google Scholar : PubMed/NCBI
22	Holzem KM, Marmerstein JT, Madden EJ and Efimov IR: Diet-induced obesity promotes altered remodeling and exacerbated cardiac hypertrophy following pressure overload. Physiol Rep. 3(pii): e124892015. View Article : Google Scholar : PubMed/NCBI
23	Pelouch V, Dixon IM, Golfman L, Beamish RE and Dhalla NS: Role of extracellular matrix proteins in heart function. Mol Cell Biochem. 129:101–120. 1993. View Article : Google Scholar : PubMed/NCBI
24	Cosaceanu D, Budiu RA, Carapancea M, Castro J, Lewensohn R and Dricu A: Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism. Oncogene. 26:2423–2434. 2007. View Article : Google Scholar : PubMed/NCBI
25	Leenders JJ, Wijnen WJ, Hiller M, van der Made I, Lentink V, van Leeuwen RE, Herias V, Pokharel S, Heymans S, de Windt LJ, et al: Regulation of cardiac gene expression by KLF15, a repressor of myocardin activity. J Biol Chem. 285:27449–27456. 2010. View Article : Google Scholar : PubMed/NCBI
26	Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, Richardson JA, Dimaio JM, Sadek H, Kuwahara K and Olson EN: Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res. 107:294–304. 2010. View Article : Google Scholar : PubMed/NCBI
27	Flanders KC, Major CD, Arabshahi A, Aburime EE, Okada MH, Fujii M, Blalock TD, Schultz GS, Sowers A, Anzano MA, et al: Interference with transforming growth factor-beta/Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. Am J Pathol. 163:2247–2257. 2003. View Article : Google Scholar : PubMed/NCBI
28	Tian Y and Morrisey EE: Importance of myocyte-nonmyocyte interactions in cardiac development and disease. Circ Res. 110:1023–1034. 2012. View Article : Google Scholar : PubMed/NCBI